The amniotic fluid transcriptome as a guide to understanding fetal disease

Cold Spring Harbor Perspectives in Medicine

Volumn 5, Issue 4, 2015, Pages

  Zwemer, Lillian M ^a   Bianchi, Diana W ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME; RNA;

AMNION FLUID; AMNION FLUID ANALYSIS; AMNION FLUID LEVEL; ANEUPLOIDY; ARTICLE; DOWN SYNDROME; EDWARDS SYNDROME; ENVIRONMENTAL EXPOSURE; FETAL THERAPY; FETUS; FETUS DEVELOPMENT; FETUS DISEASE; GENE EXPRESSION; GESTATIONAL AGE; HUMAN; MATERNAL AGE; MATERNAL OBESITY; RNA SEQUENCE; SECOND TRIMESTER PREGNANCY; TURNER SYNDROME; TWIN TWIN TRANSFUSION SYNDROME; ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; PATHOPHYSIOLOGY; PREGNANCY; PRENATAL DIAGNOSIS;

AMNIOTIC FLUID; ANIMALS; FEMALE; FETAL DISEASES; FETUS; GENE EXPRESSION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOME, HUMAN; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; RNA; TRANSCRIPTOME;

EID: 84926314172     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a023101     Document Type: Article

References (44)

1. Altug-Teber O, Bonin M, Walter M, Mau-Holzmann UA, Dufke A, Stappert H, Tekesin I, Heilbronner H, Nieselt K, Riess O. 2007. Specific transcriptional changes in human fetuses with autosomal trisomies. Cytogenet Genome Res 119: 171–184.
2. Baty BJ, Blackburn BL, Carey JC. 1994. Natural history of trisomy 18 and trisomy 13: I: Growth, physical assess-ment, medical histories, survival, and recurrence risk. Am J Med Genet 49: 175–188.
3. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 47: 289– 300.
4. Bianchi DW, Parker RL, Wentworth J, Madankumar R, Saffer C, Das AF, Craig JA, Chudova DI, Devers PL, Jones KW, et al. 2014. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 370: 799–808.
5. Bolstad BM. 2004. “Low level analysis of high-density oli-gonucleotide array data: Background, normalization and summarization.” PhD thesis, University of California, Berkeley.
6. Canick JA, Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE. 2013. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. Prenatal Diagn 33: 667– 674.
7. Clausen FB. 2014. Integration of noninvasive prenatal pre-diction of fetal blood group into clinical prenatal care. Prenatal Diagn 34: 409–415.
8. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. 2003. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
9. Duan Q, Flynn C, Niepel M, Hafner M, Muhlich JL, Fer-nandez NF, Rouillard AD, Tan CM, Chen EY, Golub TR, et al. 2014. LINCS Canvas Browser: Interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures. Nucleic Acids Res 42: W449–W460.
10. Edlow AG, Vora NL, Hui L, Wick HC, Cowan JM, Bianchi DW. 2014. Maternal obesity affects fetal neurodevelopmental and metabolic gene expression: A pilot study. PLoS ONE 9: e88661.
11. Esposito G, Imitola J, Lu J, De Filippis D, Scuderi C, Ganesh VS, Folkerth R, Hecht J, Shin S, Iuvone T. 2008. Genomic and functional profiling of human Down syndrome neu-ral progenitors implicates S100B and aquaporin 4 in cell injury. Hum Mol Genet 17: 440–457.
12. Flegal KM, Carroll MD, Kit BK, Ogden CL. 2012. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307: 491– 497.
13. Gonsoulin W, Moise KJ Jr, Kirshon B, Cotton DB, Wheeler JM, Carpenter RJ Jr. 1990. Outcomes of twin–twin transfusion diagnosed before 28 weeks of gestation. Obstet Gynecol 75: 214–216.
14. Guedj F, Bianchi DW. 2013a. Noninvasive prenatal testing creates and opportunity for antenatal treatment of Down syndrome. Prenat Diagn 33: 614–618.
15. Guedj F, Hines D, Foley JC, Haydon PG, Bianchi DW. 2013b. Translating the transcriptome to develop antenatal treat-ments for fetuses with Down syndrome. Reprod Sci 20: 64A.
16. Guedj F, Bianchi DW, Delabar J-M. 2014. Prenatal treatment of Down syndrome: A reality? Curr Opin Obstet Gynecol 26: 92–103.
17. Hui L, Slonim DK, Wick HC, Johnson KL, Bianchi DW. 2012. The amniotic fluid transcriptome: A source of novel information about human fetal development. Obstet Gynecol 119: 111–118.
18. Hui L, Slonim DK, Wick HC, Johnson KL, Koide K, Bianchi DW. 2012. Novel neurodevelopmental information re-vealed in amniotic fluid supernatant transcripts from fetuses with trisomies 18 and 21. Hum Genet 131: 1751– 1759.
19. Hui L, Wick HC, Edlow AG, Cowan JM, Bianchi DW. 2013. Global gene expression analysis of term amniotic fluid cell-free fetal RNA. Obstet Gynecol 121: 1248–1254.
20. Hui L, Wick HC, Moise KJ Jr, Johnson A, Luks F, Haeri S, Johnson KL, Bianchi DW. 2013. Global gene expression analysis of amniotic fluid cell-free RNA from recipient twins with twin–twin transfusion syndrome. Prenat Diagn 33: 873–883.
21. Hyland CA, Gardener GJ, O’Brien H, Millard G, Gibbons K, Tremellen A, Ochoa-Garay G, Flower RL, Hyett JA. 2014. Strategy for managing maternal variant RHD alleles in Rhesus D negative obstetric populations during fetal RHD genotyping. Prenatal Diagn 34: 56–62.
22. Koide K, Slonim DK, Johnson KL, Tantravahi U, Cowan JM, Bianchi DW. 2011. Transcriptomic analysis of cell-free fetal RNA suggests a specific molecular phenotype in trisomy 18. Hum Genet 129: 295–305.
23. Lamb J, Crawford ED, Modell JW, Blat IC, Wrobel MJ, Ler-ner J, Brunet J-P, Subramanian A, Ross KN. 2006. The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease. Science 313: 1929–1935.
24. Larrabee PB, Johnson KL, Lai C, Ordovas J, Cowan JM, Tantravahi U, Bianchi DW. 2005. Global gene expression analysis of the living human fetus using cell-free messen-ger RNA in amniotic fluid. JAMA 293: 836–842.
25. Lejeune J, Gautier M, Turpin R. 1959. Study of somatic chromosomes from 9 mongoloid children. C R Hebd Seances Acad Sci 248: 1721–1722.
26. Lewis C, Hill M, Skirton H, Chitty LS. 2012. Fetal sex de-termination using cell-free fetal DNA: Service users’ ex-periences of and preferences for service delivery. Prenat Diagn 32: 735–741.
27. Li Y, Pan J, Li JL, Lee JH, Tunkey C, Saraf K, Garbe JC, Whitley MZ, Jelinsky SA, Stampfer MR, et al. 2007. Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome se-nescence barriers and become immortalized. Mol Cancer 6: 7.
28. Massingham LJ, Johnson KL, Scholl TM, Slonim DK, Wick HC, Bianchi DW. 2014. Amniotic fluid RNA gene expression profiling provides insights into the phenotype of Turner syndrome. Hum Genet 133: 1075–1082.
29. Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, Anderson P, Mason CA, Collins JS, Kirby RS, et al. 2010. Updated National Birth Prevalence estimates for selected birth defects in the United States. Birth Defects Res A Clin Mol Teratoli 88: 1008–1016.
30. Rasmussen SA, Wong LY, Yang Q, May KM, Friedman JM. 2003. Population-based analyses of mortality in trisomy 13 and 18. Pediatrics 111: 777–784.
31. Rava RP, Srinivasan A, Sehnert AJ, Bianchi DW. 2014. Cir-culating fetal cell-free fractions differ in autosomal aneuploidies and monosomy X. Clin Chem 60: 243–250.
32. Roberts D, Gates S, Kilby M, Neilson JP. 2008. Interventions for twin-twin transfusion syndrome: A Cochrane review. Ultrasound Obstet Gynecol 31: 701–711.
33. Sambuy Y, De Angelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F. 2005. The Caco-2 cell line as a model of the intestinal barrier: Influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol 21: 1–26.
34. Saunders NJ, Snijders RJ, Nicolaides KH. 1992. Therapeutic amniocentesis in twin–twin transfusion syndrome ap-pearing in the second trimester of pregnancy. Am J Obstet Gyncol 166: 820–824.
35. Senat MV, Deprest J, Boulvain M, Paupe A, Winer N, Ville Y. 2004. Endoscopic laser surgery versus serial amnioreduc-tion for severe twin-to-twin transfusion syndrome. N Engl J Med 351: 136–144.
36. Shah DM and Chaffin D. 1989. Perinatal outcome in very preterm births with twin–twin transfusion syndrome. Am J Obstet Gynecol 161: 1111–1113.
37. Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW. 2009. Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses. Proc Natl Acad Sci 106: 9425–9429.
38. Song Y, Liu C, Qi H, Zhang Y, Bian X, Liu J. 2013. Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population. Prenat Diagn 33: 700–706.
39. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. 2005. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. PNAS 102: 15545– 15550.
40. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Koayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF. 2000. Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicity testing. Environ Mol Mutagen 35: 206–221.
41. Visscher M, Narendran V. 2014. The ontogeny of skin. Adv Wound Care (New Rochelle) 3: 291–303.
42. Wick HC, Drabkin H, Ngu H, Sackman M, Fournier C, Haggett J, Blake JA, Bianchi DW, Slonim DK. 2014. DFLAT: Functional annotation for human development. BMC Bioinformatics 15: 45.
43. Wu C, Orozco C, Boyer J, Leglise M, Goodale J, Batalov S, Hodge CL, Haase J, Janes J, Huss JW, et al. 2009. BioGPS: An extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10: R130.
44. Zwemer LM, Hui L, Wick HC, Bianchi DW. 2014. RNA-Seq and expression microarray highlight different aspects of the fetal amniotic fluid transcriptome. Prenat Diagn 34: 1006–1014.